These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15021899)

  • 21. Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions.
    Scharnhorst V; Dekker P; van der Eb AJ; Jochemsen AG
    J Biol Chem; 2000 Apr; 275(14):10202-11. PubMed ID: 10744705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay.
    Monti P; Campomenosi P; Ciribilli Y; Iannone R; Aprile A; Inga A; Tada M; Menichini P; Abbondandolo A; Fronza G
    Oncogene; 2003 Aug; 22(34):5252-60. PubMed ID: 12917626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies raised against Xenopus p53 interact with human p73.
    Le Bras M; Delattre V; Bensaad K; Blandino G; Soussi T
    Oncogene; 2002 Feb; 21(8):1304-8. PubMed ID: 11850851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
    Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
    Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural diversity of p63 and p73 isoforms.
    Osterburg C; Dötsch V
    Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 and MDMX bind and stabilize the p53-related protein p73.
    Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
    Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
    Zhang L; Nie L; Maki CG
    Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
    Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
    Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.
    Roth J; König C; Wienzek S; Weigel S; Ristea S; Dobbelstein M
    J Virol; 1998 Nov; 72(11):8510-6. PubMed ID: 9765388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.
    Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A
    Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
    Papadogianni D; Soulitzis N; Delakas D; Spandidos DA
    Tumour Biol; 2014 Mar; 35(3):2481-9. PubMed ID: 24213852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.
    Huqun ; Endo Y; Xin H; Takahashi M; Nukiwa T; Hagiwara K
    Cancer Sci; 2003 Aug; 94(8):718-24. PubMed ID: 12901798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure, function and regulation of p63 and p73.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
    Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
    Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
    J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.